A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Seattle Children's Hospital
Universitätsklinikum Hamburg-Eppendorf
Milton S. Hershey Medical Center
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Hackensack Meridian Health
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Massachusetts General Hospital
Thomas Jefferson University
The University of Texas Health Science Center, Houston
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Texas Southwestern Medical Center
Celgene
Istari Oncology, Inc.
The Hospital for Sick Children
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
University of Alabama at Birmingham
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Eastern Cooperative Oncology Group
Centre Leon Berard
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Bexion Pharmaceuticals, Inc.
Northwestern University
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Lumos Pharma
Emory University
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
University of Washington